Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.
To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Platelet activating factor
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).
Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).
Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Ambrosio G and Tritto I | Reperfusion injury: experimental evidence and clinical implications. | 1999 | Am. Heart J. | pmid:10426862 |
Maruyama M et al. | Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs. | 1990 | Am. Heart J. | pmid:2389687 |
Schwinger RH et al. | Existence of PAF receptors in human platelets and human lung tissue but not in the human myocardium. | 1992 | Am. Heart J. | pmid:1322030 |
Kwiterovich PO | The antiatherogenic role of high-density lipoprotein cholesterol. | 1998 | Am. J. Cardiol. | pmid:9819099 |
Madsen NJ et al. | Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents. | 2007 | Am. J. Cardiol. | pmid:17697836 |
Shohet RV et al. | Plasma platelet-activating factor acetylhydrolase activity is not associated with premature coronary atherosclerosis. | 1999 | Am. J. Cardiol. | pmid:10073795 |
Zhang C et al. | The effect of Ginkgo biloba extract (EGb 761) on hepatic sinusoidal endothelial cells and hepatic microcirculation in CCl4 rats. | 2004 | Am. J. Chin. Med. | pmid:15154282 |
Prescott SM | What are the effects of dietary fatty acid modification on platelet eicosanoid metabolism, platelet-activating factor, and platelet function? How might these metabolic alterations influence thrombosis? | 1992 | Am. J. Clin. Nutr. | pmid:1414987 |
Sandler RM et al. | Heparin-induced thrombocytopenia and thrombosis: detection and specificity of a platelet-aggregating IgG. | 1985 | Am. J. Clin. Pathol. | pmid:4003343 |
Sandberg-Gertzén H | An open trial of Cedemin, a Gingko biloba extract with PAF-antagonistic effects for ulcerative colitis. | 1993 | Am. J. Gastroenterol. | pmid:8470656 |
Braquet P | Cedemin, a Ginkgo biloba extract, should not be considered as a PAF antagonist. | 1993 | Am. J. Gastroenterol. | pmid:8110248 |
Verhoef G and Boogaerts M | Treatment with granulocyte-macrophage colony stimulating factor and the adult respiratory distress syndrome. | 1991 | Am. J. Hematol. | pmid:1672790 |
Rao AK et al. | Platelet-activating factor is a weak platelet agonist: evidence from normal human platelets and platelets with congenital secretion defects. | 1984 | Am. J. Hematol. | pmid:6431801 |
Issekutz AC and Ripley M | The effect of intravascular neutrophil chemotactic factors on blood neutrophil and platelet kinetics. | 1986 | Am. J. Hematol. | pmid:2934975 |
Radhika V et al. | Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants. | 1996 | Am. J. Hematol. | pmid:8756080 |
Lo GK et al. | What is the potential for overdiagnosis of heparin-induced thrombocytopenia? | 2007 | Am. J. Hematol. | pmid:17722079 |
Marx G et al. | Nutritional zinc increases platelet reactivity. | 1991 | Am. J. Hematol. | pmid:1951315 |
Pelczar-Wissner CJ et al. | Absence of platelet activating factor (PAF) mediated platelet aggregation: a new platelet defect. | 1984 | Am. J. Hematol. | pmid:6720685 |
Yoshida H et al. | Activity of platelet-activating factor acetylhydrolase exists in red cell membrane. | 1992 | Am. J. Hematol. | pmid:1566749 |
Greinacher A | Too many hits in HIT? | 2007 | Am. J. Hematol. | pmid:17729242 |
Hollister AS et al. | Humoral factor, intraplatelet calcium, and hypertension. | 1992 | Am. J. Hypertens. | pmid:1632935 |
Macconi D et al. | Defective platelet aggregation in response to platelet-activating factor in uremia associated with low platelet thromboxane A2 generation. | 1992 | Am. J. Kidney Dis. | pmid:1562019 |
Tetta C et al. | Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments. | 1997 | Am. J. Kidney Dis. | pmid:9372980 |
Tanaka R et al. | Role of platelet-activating factor acetylhydrolase gene mutation in Japanese childhood IgA nephropathy. | 1999 | Am. J. Kidney Dis. | pmid:10430976 |
Hall AV et al. | Abrogation of MRL/lpr lupus nephritis by dietary flaxseed. | 1993 | Am. J. Kidney Dis. | pmid:8352261 |
Gallego MJ et al. | Cyclosporine enhances leukocyte adhesion to vascular endothelium under physiologic flow conditions. | 1996 | Am. J. Kidney Dis. | pmid:8712218 |
Xu H et al. | Platelet-activating factor acetylhydrolase gene mutation in Japanese children with Escherichia coli O157-associated hemolytic uremic syndrome. | 2000 | Am. J. Kidney Dis. | pmid:10873870 |
Barnes PJ | Inflammatory mechanisms and nocturnal asthma. | 1988 | Am. J. Med. | pmid:3041827 |
Wasserman SI | The mast cell and theophylline in asthma. | 1985 | Am. J. Med. | pmid:3002176 |
Wright NR et al. | Purulent Pericarditis and Abscessed Myocardium with Acute Myocardial Infarction. | 2016 | Am. J. Med. | pmid:26524710 |
Ganong BR | Roles of lipid turnover in transmembrane signal transduction. | 1991 | Am. J. Med. Sci. | pmid:1661067 |
Muirhead EE et al. | Biologic contrasts between medullipin I and vasoactive glyceryl compounds. | 1989 | Am. J. Med. Sci. | pmid:2764021 |
Gaylord MS et al. | Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia. | 1996 | Am. J. Med. Sci. | pmid:8853062 |
Pitcock JA | Morphometric studies of the renomedullary interstitial cells. | 1988 | Am. J. Med. Sci. | pmid:3284348 |
Perico N and Remuzzi G | Role of platelet-activating factor in renal immune injury and proteinuria. | 1990 | Am. J. Nephrol. | pmid:2256482 |
Kees-Folts D and Diamond JR | Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis in the nephrotic syndrome. | 1993 | Am. J. Nephrol. | pmid:8116689 |
Camussi G et al. | Platelet-activating factor in renal diseases. | 1989 | Am. J. Nephrol. | pmid:2646923 |
Wild MD and Roudebush WE | Platelet-activating factor improves intrauterine insemination outcome. | 2001 | Am. J. Obstet. Gynecol. | pmid:11349157 |
Hoffman DR et al. | The role of platelet-activating factor in human fetal lung maturation. | 1986 | Am. J. Obstet. Gynecol. | pmid:3728606 |
Tabor BL et al. | Platelet-activating factor antagonists decrease lung protein leak in preterm ventilated rabbits. | 1992 | Am. J. Obstet. Gynecol. | pmid:1530043 |
Narahara H and Johnston JM | Effects of endotoxins and cytokines on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages. | 1993 | Am. J. Obstet. Gynecol. | pmid:8372856 |
Claman P | Platelet activating factor does not improve intrauterine insemination outcome. | 2001 | Am. J. Obstet. Gynecol. | pmid:11717679 |
Benedetto C et al. | Reduced serum inhibition of platelet-activating factor activity in preeclampsia. | 1989 | Am. J. Obstet. Gynecol. | pmid:2912073 |
Morris C et al. | Effects of platelet-activating factor on prostaglandin E2 production by intact fetal membranes. | 1992 | Am. J. Obstet. Gynecol. | pmid:1566774 |
Maul H et al. | Local application of platelet-activating factor induces cervical ripening accompanied by infiltration of polymorphonuclear leukocytes in rats. | 2002 | Am. J. Obstet. Gynecol. | pmid:12388958 |
Zhu YP et al. | The presence of platelet-activating factor binding sites in human myometrium and their role in uterine contraction. | 1992 | Am. J. Obstet. Gynecol. | pmid:1314480 |
Rowland BL et al. | Elevated circulating concentrations of platelet activating factor in preeclampsia. | 2000 | Am. J. Obstet. Gynecol. | pmid:11035340 |
Matorras R and Pijoan JI | The improvement in pregnancy rates with platelet-activating factor in intrauterine insemination was not demonstrated. | 2002 | Am. J. Obstet. Gynecol. | pmid:11904634 |
Hoffman DR et al. | Detection of platelet-activating factor in amniotic fluid of complicated pregnancies. | 1990 | Am. J. Obstet. Gynecol. | pmid:2309839 |
Thaete LG and Neerhof MG | Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat. | 2006 | Am. J. Obstet. Gynecol. | pmid:16579936 |
Roudebush WE et al. | Platelet activating factor enhances in vitro fertilization of rabbit oocytes. | 1990 | Am. J. Obstet. Gynecol. | pmid:2240122 |
Minhas BS et al. | Effects of platelet activating factor on mouse oocyte fertilization in vitro. | 1989 | Am. J. Obstet. Gynecol. | pmid:2603931 |
Frostegård J et al. | Antibodies against platelet-activating factor and platelet-activating factor-like lipids are raised in women with primary recurrent abortion. | 2003 | Am. J. Obstet. Gynecol. | pmid:14520236 |
Silver RK et al. | Anticardiolipin antibody-positive serum enhances endothelial cell platelet-activating factor production. | 1991 | Am. J. Obstet. Gynecol. | pmid:1750472 |
Minhas BS | Platelet-activating factor treatment of human spermatozoa enhances fertilization potential. | 1993 | Am. J. Obstet. Gynecol. | pmid:8475981 |
Sueoka K et al. | Platelet activating factor-induced early pregnancy factor activity from the perfused rabbit ovary and oviduct. | 1988 | Am. J. Obstet. Gynecol. | pmid:3207134 |
Montrucchio G et al. | Potential angiogenic role of platelet-activating factor in human breast cancer. | 1998 | Am. J. Pathol. | pmid:9811351 |
O'Flaherty JT et al. | Neutrophil-degranulating action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Comparison with other degranulating agents. | 1981 | Am. J. Pathol. | pmid:6274199 |
Reznichenko A and Korstanje R | The role of platelet-activating factor in mesangial pathophysiology. | 2015 | Am. J. Pathol. | pmid:25655028 |
Rampart M and Williams TJ | Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration. | 1986 | Am. J. Pathol. | pmid:3524253 |
Lehr HA et al. | In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation. | 1995 | Am. J. Pathol. | pmid:7531948 |
Byrne SN et al. | The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation. | 2011 | Am. J. Pathol. | pmid:21703403 |
Montrucchio G et al. | Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. | 1997 | Am. J. Pathol. | pmid:9250168 |
Zhou WG et al. | Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat. | 1990 | Am. J. Pathol. | pmid:1701964 |
O'Flaherty JT et al. | 1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants. | 1981 | Am. J. Pathol. | pmid:7223864 |
Boccellino M et al. | Platelet-activating factor regulates cadherin-catenin adhesion system expression and beta-catenin phosphorylation during Kaposi's sarcoma cell motility. | 2005 | Am. J. Pathol. | pmid:15855650 |
Montrucchio G et al. | Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart. | 1990 | Am. J. Pathol. | pmid:2372044 |
Singh TP et al. | Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice. | 2011 | Am. J. Pathol. | pmid:21281802 |
Koyama S et al. | Bradykinin stimulates type II alveolar cells to release neutrophil and monocyte chemotactic activity and inflammatory cytokines. | 1998 | Am. J. Pathol. | pmid:9846978 |
Masubuchi T et al. | Smoke extract stimulates lung epithelial cells to release neutrophil and monocyte chemotactic activity. | 1998 | Am. J. Pathol. | pmid:9846980 |
Stimler NP and O'Flaherty JT | Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues. | 1983 | Am. J. Pathol. | pmid:6624879 |
Wolf P et al. | Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis. | 2006 | Am. J. Pathol. | pmid:16936256 |
Warren JS | Relationship between interleukin-1 beta and platelet-activating factor in the pathogenesis of acute immune complex alveolitis in the rat. | 1992 | Am. J. Pathol. | pmid:1519663 |
Flickinger BD and Olson MS | Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells. | 1999 | Am. J. Pathol. | pmid:10329588 |
O'Flaherty JT et al. | Role of extracellular calcium and neutrophil degranulation responses to 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. | 1981 | Am. J. Pathol. | pmid:6271016 |
Souza-Fiho MV et al. | Involvement of nitric oxide in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis. | 1997 | Am. J. Pathol. | pmid:9006340 |
Valone FH and Goetzl EJ | Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC). | 1983 | Am. J. Pathol. | pmid:6624880 |
Bussolati B et al. | PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. | 2000 | Am. J. Pathol. | pmid:11073830 |
Sun XM et al. | Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor. | 1990 | Am. J. Pathol. | pmid:2327475 |
Doi K et al. | Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. | 2006 | Am. J. Pathol. | pmid:16651609 |
McManus LM and Pinckard RN | Kinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit. | 1985 | Am. J. Pathol. | pmid:4050977 |
Montrucchio G et al. | Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart. | 1993 | Am. J. Pathol. | pmid:8434642 |
Hsueh W et al. | Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis. | 1986 | Am. J. Pathol. | pmid:3080895 |
Bussolati B et al. | Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change. | 1999 | Am. J. Pathol. | pmid:10027419 |
Elovitz MA et al. | A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. | 2003 | Am. J. Pathol. | pmid:14578208 |
Gonzalez-Crussi F and Hsueh W | Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. | 1983 | Am. J. Pathol. | pmid:6859226 |
Camussi G et al. | Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor. | 1983 | Am. J. Pathol. | pmid:6859232 |
Kispert S et al. | Cigarette Smoke Regulates Calcium-Independent Phospholipase A Metabolic Pathways in Breast Cancer. | 2017 | Am. J. Pathol. | pmid:28618256 |
Stimler NP et al. | Anaphylactic actions of platelet-activating factor. | 1981 | Am. J. Pathol. | pmid:6975043 |
Shaw JO and Henson PM | The binding of rabbit basophil-derived platelet-activating factor to rabbit platelets. | 1980 | Am. J. Pathol. | pmid:6987890 |
Zhou W et al. | Role of platelet-activating factor in pancreatitis-associated acute lung injury in the rat. | 1992 | Am. J. Pathol. | pmid:1562055 |
Zhou W et al. | Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperstimulation. | 1993 | Am. J. Pathol. | pmid:8494049 |
Humphrey DM | Inflammatory exudates in skin windows induced by 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine. | 1990 | Am. J. Pathol. | pmid:2407127 |
Biancone L et al. | Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis. | 1999 | Am. J. Pathol. | pmid:10550329 |
Emanuelli G et al. | Experimental acute pancreatitis induced by platelet activating factor in rabbits. | 1989 | Am. J. Pathol. | pmid:2464939 |
Del Maschio A et al. | Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. | 1990 | Am. J. Physiol. | pmid:2156456 |
Kim D and Durán WN | Platelet-activating factor stimulates protein tyrosine kinase in hamster cheek pouch microcirculation. | 1995 | Am. J. Physiol. | pmid:7530921 |
Greenberg SG and Clark KE | Hemodynamic effects of platelet-activating factor in nonpregnant and pregnant sheep. | 1999 | Am. J. Physiol. | pmid:10516237 |
Snyder F | Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. | 1990 | Am. J. Physiol. | pmid:2240190 |
Dorn GW and Davis MG | Differential megakaryocytic desensitization to platelet agonists. | 1992 | Am. J. Physiol. | pmid:1415671 |